Trial Profile
A Retrospective, Single Center Study to Assess the Efficacy of Leflunomide in BK-viremia and Biopsy Proven BK Nephropathy in Kidney and Kidney-pancreas Transplant Recipient.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Leflunomide (Primary)
- Indications Human polyomavirus infections; Kidney disorders; Kidney-pancreas transplant rejection; Renal transplant rejection
- Focus Therapeutic Use
- 24 Aug 2015 New trial record